Filter
3402
Filtered Results: 3402
Text search:
The
Lancet
Global
Health
Featured
Recommendations
262
New Publications
592
Language
Document type
No document type
1568
Studies & Reports
956
Guidelines
442
Manuals
141
Strategic & Response Plan
110
Fact sheets
80
Training Material
55
Situation Updates
22
Infographics
15
Resource Platforms
7
Brochures
3
Online Courses
2
Videos
1
Countries / Regions
Global
218
India
83
Latin America and the Carribbean
77
Western and Central Europe
71
Africa
70
South Africa
69
Kenya
61
Brazil
58
Ethiopia
57
Russia
55
Nigeria
47
Eastern Europe
45
Sierra Leone
42
Malawi
39
Senegal
38
Liberia
34
Zambia
34
Uganda
33
Congo, Democratic Republic of
32
Mozambique
31
Ukraine
31
Germany
30
Nepal
28
Rwanda
26
Syria
25
Bangladesh
25
Asia
25
Tanzania
23
Guinea
22
Burkina Faso
21
Ghana
21
West and Central Africa
20
Zimbabwe
19
South–East Asia Region
19
Cameroon
18
Myanmar / Burma
17
East and Southern Africa
17
Middle East and North Africa
17
Philippines
16
Haiti
15
Colombia
15
Yemen
15
Eastern Europe and Central Asia
15
Venezuela
15
Indonesia
14
Benin
14
Chile
14
Angola
12
Mali
11
Cambodia
11
Madagascar
11
Lesotho
11
South Sudan
10
Botswana
10
Namibia
9
Peru
9
Argentina
8
Eswatini/ Swaziland
8
Ecuador
8
Western Pacific Region
8
Paraguay
8
North America
8
Spain
8
Somalia
7
Sudan
7
Vietnam
7
Guinea-Bissau
6
Côte d’Ivoire / Ivory Coast
6
Niger
6
Pakistan
6
Afghanistan
6
Chad
5
Thailand
5
China
5
Central African Republic
5
Mexico
5
Italy
5
Portugal
5
USA
4
Iraq
4
Jordan
4
El Salvador
4
Albania
4
Southern Africa
4
Tajikistan
4
France
4
United Kingdom
4
Lebanon
3
Burundi
3
Bolivia
3
Sri Lanka
3
Laos
3
Kyrgyzstan
3
Kazakhstan
3
Belarus
3
Israel
3
Turkey
2
Egypt
2
Honduras
2
Guatemala
2
Nicaragua
2
Palestine
2
Armenia
2
Congo-Brazzaville
2
Qatar
2
Romania
2
Moldova
2
Georgia
2
Uruguay
2
Jamaica
2
Morocco
1
Saudi Arabia
1
Mauritania
1
Dominican Republic
1
North Macedonia
1
Switzerland
1
Hungary
1
Cuba
1
Greece
1
Libya
1
Poland
1
Canada
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Slovakia
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
950
Clinical Guidelines
325
Public Health
232
Women & Child Health
217
Key Resources
98
Pharmacy & Technologies
37
Capacity Building
36
Toolboxes
COVID-19
421
HIV
323
Mental Health
288
TB
245
Planetary Health
202
NCDs
137
AMR
118
NTDs
110
Caregiver
105
Global Health Education
94
Disability
85
Health Financing Toolbox
79
Ebola
71
Rapid Response
70
Refugee
46
Conflict
41
Pharmacy
32
Zika
30
Polio
20
Cholera
19
Natural Hazards
17
Social Ethics
6
Specific Hazards
2
Health Financing
2
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, w...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, w...
The framework responds to the demand from Member States and partners for guidance on how the health...
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child healt... (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how aid flows for newborn care can be tracked, examined changes in the last decade, and considered methodological implications for tracking funding for specific population groups or diseases. MethodsandFindings:We critically reviewed and categorised previous analyses of aid to specific populations, diseases, or types of activities. We then developed and refined key terms related to newborn survival in seven languages and searched titles and descriptions of donor disbursement records in the Organisation for Economic Co-operation and Development’s Creditor Reporting System database, 2002–2010. We compared results with the Countdown to 2015 database of aid for MNCH (2003–2008) and the search strategy used by the Institute for Health Metrics and Evaluation. Prior to 2005, key terms related to newborns were rare in disbursement records but their frequency increased markedly thereafter. Only two mentions were found of ‘‘stillbirth’’ and only nine references were found to ‘‘fetus’’ in any spelling variant or language
The scale of West Africa’s Ebola epidemic has been attributed to the weak health systems of affected countries,
their lack of resources, ... mobility of communities and their inexperience in dealing with Ebola. This briefing for African Affairs argues that these explanations lack important context. The briefing examines responses to the outbreak and offers a different set of explanations, rooted in the history of the region and the political economy of global health and development. To move past technical discussions of “weak” health systems, it highlights how structural violence has contributed to the epidemic. As part of this, local people – their beliefs, concerns and priorities – have been marginalised. Both the crisis response and post-Ebola ‘reconstruction’ will be strengthened by acknowledgment of its long term structural underpinnings and from a more collaborative inclusion of local people.
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low...
Antibiotic resistance has been recognized as a major global health threat and optimizing prescribing is one of the most effective measures...
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and como...
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to o...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). ... primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the patient, health-care provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including: (1) effective measures for tobacco control; (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of health care through task-sharing (non-physician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above, will lead to substantial reductions in CVD and related mortality.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the succ...
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-spe...
During the first year of the Covid-19 pandemic, the world’s economy slowed. Yet, the ... annual average particulate pollution (PM2.5) was largely unchanged from 2019 levels. At the same time, growing evidence shows air pollution—even when experienced at very low levels—hurts human health. This recently led the World Health Organization (WHO) to revise its guideline for what it considers a safe level of exposure of particulate pollution, bringing most of the world—97.3 percent of the global population—into the unsafe zone. The AQLI finds that particulate air pollution takes 2.2 years off global average life expectancy, or a combined 17 billion life-years, relative to a world that met the WHO guideline. This impact on life expectancy is comparable to that of smoking, more than three times that of alcohol use and unsafe water, six times that of HIV/AIDS, and 89 times that of conflict and terrorism.
Cardiovascular disease, diabetes, chronic obstructive pulmonary disease, cancers, and other non-communicable diseases are among the leading causes of morbidity and mortality in low-income, middle-income, and high-income countries, and ... Lancet Taskforce recently made the case for investing in non-communicable disease prevention. Now, in The Lancet Planetary Health, Benjamin Bowe and colleagues report that exposure to PM2·5 air pollution is indeed a risk factor for diabetes.
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the ... Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for antimicrobial stewardship (AMS). Within each country, different healthcare challenges have
contributed to AMR. This has also shaped individual AMS strategies and policies. In South Africa (SA), there is a high burden of infectious diseases, mainly of bacterial origin. In addition, SA also has the highest number of people living with
human immunodeficiency virus (HIV) globally. According to the 2019 statistics, there are approximately 7.97 million people living with HIV in SA. Together with this, SA has the fourth largest tuberculosis population globally.
Other important challenges include poverty, malnutrition, a high burden of non-communicable diseases, and a dire shortage of trained healthcare professionals (e.g. clinicians, pharmacists, and nurses).
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential ... public health treat of major concern.
Several factors are contributing to the (re)emergence of infectious diseases such as population growth, living in close contact with animals, frequent travelling, poverty, destructive ecological changes due to economic development and land use and climate change result in global warming.
Especially Africa is at a threat for (re)emerging infectious diseases due to the huge population growth (expected to reach 2.5 billion by 2050) with rapid urbanisation. Additionally, people across and beyond the continent are excessively mobile which is combined with a weak health system. Moreover, the risk of (re)emerging infectious disease is further heightened by three newly adopted continental initiatives: African Continental Free Trade Area, Free Movement of Persons and African Passport and Single African Air Transport Market.
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tu...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distr...
